Literature DB >> 3946541

Absence of antibody production in patients treated with botulinum A toxin.

A W Biglan, R Gonnering, L B Lockhart, B Rabin, F H Fuerste.   

Abstract

To test the possibility of the formation of an antibody to botulinum A toxin after multiple injections of this potent neurotoxin, we collected serum samples from 28 patients who received 57 doses. These injections over a nine-month period with as much as 50 units per injection formed no detectable antibody.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3946541     DOI： 10.1016/0002-9394(86)90601-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


  6 in total

1.  Polyradiculoneuritis following botulinum toxin therapy.

Authors:  B A Haug; D Dressler; H W Prange
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

2.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

Authors:  J Jankovic; K Schwartz; D T Donovan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

Review 3.  Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.

Authors:  S P Kraft; A E Lang
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

4.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

Authors:  G L Sheean; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

5.  Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.

Authors:  J S Elston
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

Review 6.  [Antibody-induced failure of botulinum toxin therapy].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2003-12       Impact factor: 1.214
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.